FGM-15319-00478
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 625 / IL
- Registered
- 2022-07-06
- Relationship
- Child or adolescent in my care
- Guardian
- VGX-57545-26971
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-05
Dose 1 — Pfizer-BioNTech
-
2022-07-06
Registered in v-safe
- 2022-07-06
- 2022-07-07
- 2022-07-08
- 2022-07-09
- 2022-07-10
- 2022-07-11
- 2022-07-12
- 2022-07-19
- 2022-07-28
-
2022-08-04
Survey response — day 28, dose 1, dependentMedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: Cold symptoms - runny nose, coughingMedDRA releases: 2024-11 · check-in free text available
-
2022-08-09
Dose 2 — Pfizer-BioNTech
- 2022-08-09
- 2022-08-13
- 2022-08-14
- 2022-08-18
- 2022-08-25
- 2022-09-01
- 2022-09-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-05 | Pfizer-BioNTech | No |
| 2 | 2022-08-09 | Pfizer-BioNTech | No |
Free text
Release 12 — day 28, dose 1, dependent
Symptoms: Cold symptoms - runny nose, coughing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release